Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTENTION IA: IA Tenecteplase after EVT in Posterior Circulation Stroke
NCT05684172Phase 3Completed
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by The First Affiliated Hospital of University of Science and Technology of China. Started Jan 2023; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05684172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684172.